The prior liver cancer associated with chronic viral liver diseases
https://doi.org/10.22625/2072-6732-2009-1-4-55-59
Abstract
In issue the experience of treatment in 67 patients with the prior liver cancer is presented. The hepatocellular cancer was diagnosed in 62 cases (92,5%), cholangiocellular cancer in the rest 5 patients. Viral hepatitis B was evaluated in 28 cases, viral hepatitis C in 19. Surgical treatment was performed in 34, in 22 resection of liver was carried out in cases with chronical viral hepatitis and cirrhosis. 16 (47,1%) patients had complications in postoperative period, hepatocellular insufficiency developed more often in patients with viral lesions. Postoperative mortality was in 17,6%. The 5-year survival was 47±7,2%. 49,3% patients got regional chemotherapy – chemoembolization or chemoinfusion in hepatic artery. Mediana was 19,4 and 10,2 months, consequently. So, patients with viral hepatitis and cirrhosis have more complications in postoperative period after liver resections. Surgical approach needs very careful evaluation of cancer dissemination and liver dysfunction in this category of patients.
About the Authors
B. N. Kotiv
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
I. I. Dzidzava
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
S. A. Alentiev
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
A. A. Ivanova
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
D. P. Kashkin
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
A. V. Slobodanik
Military-Medical Academy of S.M.Kirov, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Базин И.С. Гепатоцеллюлярный рак – современное состояние проблемы / И.С. Базин // Практическая онкология. – 2008. – Т.9, №4. – С.216–228.
2. Патютко Ю.И. хирургическое лечение злокачественных опухолей печени / Ю.И. Патютко. – М.: Практическая медицина, 2005. – 312 с.
3. Ярошенко Е.Б. Роль вирусных гепатитов в развитии гепатоцеллюлярной карциномы / Е.Б. Ярошенко, Э.З. Бурневич, Я.Г. Мойсюк // Практическая онкология. –2008. – Т.9, №4. – С.189–193.
4. Fan S.T. Hepatectomy with anultrasonic dissector for hepatocellular carcinoma / S.T. Fan, E.G. Lai, C.M. Lo // Br. J. Surg. – 1996. – Vol. 83, №4. – P.117–120.
5. Bosh F.X. Epidemiology of primery liver cancer / F.X. Bosh, J. Ribes, J. Borras // Semin. Liver Dis. – 1999. – Vol. 19. – P.271–285.
6. Исламбеков З.А. Сравнительная оценка методов лечения гепатоцеллюлярного рака / З.А. Исламбеков, М.Д. Джураев // Анн. хир. гепатол. – 2009. – Т.14, №2. – С.59–63.
7. Интервенционная радиология в онкологии (пути развития и технологии): Научно-практическое издание/ гл. ред.: А.М. Гранов, М.И. Давыдов; ред.: П.Г. Таразов, Д.А. Гранов, Б.И. Долгушин, В.Н. Полысалов, А.А. Поликарпов. – СПб: ООО «Издательство ФОЛИАНТ», 2007. – 344с.
8. Nagasue N. Liver resection for hepatocellular carcinoma. Result of 229 consecutive patients during 11 years / N. Nagasue, H. Kohno, Y.C. Chang et al. // Ann. Surg. – 1993. – Vol. 217. – P. 375–384.
9. Lygidakis J. Resution versus resection covbined with adjuvant pre- and post- jhtrative chemotherapy-immunotherapy for liver cancer. A New look at an old problem / J. Lygidakis // Hepato-gastroenterol. – 1995. – Vol. 42. – Р.155–161.
10. Kawarad A. Cholangiocellular of the liver / A. Kawarad, R. Mizumoto // Amer. J. Surg. – 1994. Vol. 3. – P. 354–359.
11. Litle S.A. Hepatocellular carcinoma: current surgical management / S.A. Litle, Y. Fong // Semin. Oncol. – 2001. –Vol. 28. – P. 474–486.
Review
For citations:
Kotiv B.N., Dzidzava I.I., Alentiev S.A., Ivanova A.A., Kashkin D.P., Slobodanik A.V. The prior liver cancer associated with chronic viral liver diseases. Journal Infectology. 2009;1(4):55-59. (In Russ.) https://doi.org/10.22625/2072-6732-2009-1-4-55-59
Views:
851
.png)
.png)
Email this article 